Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma

计划入组 56 人 · 首次发布于 2013 年 9 月 26 日

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

计划入组 504 人 · 首次发布于 2017 年 7 月 13 日

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

计划入组 140 人 · 首次发布于 2017 年 7 月 13 日

NeuroNova 1

CLD-101

Gene-Edited Cells(Neurona Therapeutics)

Neuronoff, Inc.

United States

FERRONOVA PTY LTD

Australia

AURONOVA RES INC

United States

Calidi Biotherapeutics Advances Virotherapy Platforms for Glioma and Solid Tumors Despite Financial Losses

FDA Clears IND for Calidi Biotherapeutics' CLD-101 in High-Grade Glioma

Calidi Biotherapeutics' RTNova Platform Shows Promise in Targeting Metastatic Cancers